Prenatal use of folic acid reduced the likelihood of autism by 40%.
Women who used prenatal folic acid supplements from 4 weeks before pregnancy to 8 weeks after the start of pregnancy had a 40% reduced risk of having a child with an autistic disorder, according to the results of a population-based Norwegian study that examined more than 85,000 children. Study results were published in the Journal of the American Medical Association.
Autistic disorder was found in 0.21% of the children born to mothers who did not take folic acid, compared with 0.10% of children born to mother who did, resulting in an adjusted odds ratio for an autistic disorder of 0.61 (95% CI, 0.41-0.90).
Children in the study were born between 2002 and 2008. The study ended in March 2012. During that time, an autism spectrum disorder was diagnosed in 270 children (0.32% of the population).
The researchers pointed out that “this finding does not establish a causal relation between folic acid use and autistic disorder but provides a rationale for replicating the analyses in other study samples.”
Read the full results of the study here.
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.